Experts are warning that a medical emergency is looming in some African countries. The last batch of an effective snake-venom antidote expires next year. The company which supplies the drug is blaming high production costs for ending its manufacture.
Al Jazeera’s Ahmed Idris reports from northern Nigeria.
Source: Al Jazeera